tirzepatide macular degeneration One GLP-1 Drug May Be Better Than Rivals for Glaucoma Risk tirzepatide macular degeneration NEJM Editorial

doi:10.1021/bi902022n, PMID: 20070126 Yan Z, Garg SK, Kipnis J, Banerjee R (2009) Extracellular redox modulation by regulatory T cells

The FDA recently added a black box warning, its strongest word of caution, for users of Ozempic

Customization: Compounding allows for personalized formulas, which may not be possible with standard brand-name options

Specific recommendations include incorporating simplified questionnaires and innovative screening methods into routine care, prioritizing neurotropic B vitamin supplementation, optimizing glucagon-like peptide 1 (GLP-1) receptor agonist treatments, and adopting a holistic approach to neuropathy management

Semaglutide Therapy and Accelerated Sarcopenia in Older Adults with Type 2 Diabetes: A 24-Month Retrospective Cohort Study